STOCK TITAN

Olink Holding AB (publ) - $OLK STOCK NEWS

Welcome to our dedicated page for Olink Holding AB (publ) news (Ticker: $OLK), a resource for investors and traders seeking the latest updates and insights on Olink Holding AB (publ) stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Olink Holding AB (publ)'s stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Olink Holding AB (publ)'s position in the market.

Rhea-AI Summary
Olink Holding AB announces that Novogene Asia Pacific Middle East and Africa has adopted the Olink Explore HT platform for next-generation proteomics technology. This partnership enhances Novogene's research services offerings and allows scientists to measure over 5,400 proteins with high specificity and sensitivity. The integration of Olink technology will provide actionable data and insights into disease biology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.16%
Tags
none
-
Rhea-AI Summary
Thermo Fisher Scientific Inc. has commenced a tender offer to acquire all outstanding common shares and ADSs of Olink Holding AB for $26.00 per share and per ADS in cash. The offer will expire on November 30, 2023, and is subject to regulatory approvals and a minimum tender condition. Olink's board of directors has recommended that shareholders accept the offer. Summa Equity AB and other shareholders holding approximately 66% of Olink's shares have entered into support agreements to tender into the offer.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.89%
Tags
none
-
Rhea-AI Summary
Thermo Fisher Scientific reports Q3 2023 financial results, with revenue of $10.57 billion, a 1% decrease from the same quarter last year. GAAP diluted EPS was $4.42, a 17% increase YoY. The company also announced an agreement to acquire Olink Holding AB for $3.1 billion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.56%
Tags
Rhea-AI Summary
Thermo Fisher to acquire Olink for $3.1 billion, enhancing capabilities in the proteomics market
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
66.02%
Tags
-
Rhea-AI Summary
Olink Holding AB (Nasdaq: OLK) reports publication of three articles in Nature showcasing the power of the Olink Explore platform for proteogenomic studies. The studies used data from the UK Biobank Pharma Proteomics Project and demonstrated the value of proteogenomics in understanding biological mechanisms and accelerating drug development. The findings include over 14,000 genetic associations with protein expression levels, with 81% being novel.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.41%
Tags
none
-
Rhea-AI Summary
Olink Holding AB introduces Olink® Target 48 Mouse Cytokine Panel for translational research. The panel accurately measures 43 immune-related proteins using as little as 1µl of sample volume. It enables in-depth disease modeling and longitudinal studies. The panel's performance surpasses other platforms in the market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.1%
Tags
none
Rhea-AI Summary
Eurofins Genomics adopts Olink® technology to advance proteomics research and accelerate precision medicine programs
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.88%
Tags
none
-
Rhea-AI Summary
Olink Holding AB (OLK) to participate in investor events: Goldman Sachs 20th Annual European Medtech and Healthcare Services Conference on Sept 7th and Morgan Stanley 21st Annual Global Healthcare Conference on Sept 12th.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.49%
Tags
conferences
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.48%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.63%
Tags
none
Olink Holding AB (publ)

Nasdaq:OLK

OLK Rankings

OLK Stock Data

2.99B
40.67M
66.62%
34.6%
1.87%
Analytical Laboratory Instrument Manufacturing
Manufacturing
Link
United States of America
Uppsala

About OLK

Olink Holding AB provides accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients.